A detailed history of Rhumbline Advisers transactions in Compass Pathways PLC stock. As of the latest transaction made, Rhumbline Advisers holds 1,376 shares of CMPS stock, worth $11,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,376
Previous 1,376 -0.0%
Holding current value
$11,751
Previous $11,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
N/A
658 Added 91.64%
1,376 $11,000
Q1 2024

May 09, 2024

BUY
N/A
58 Added 8.79%
718 $6,000
Q3 2023

Nov 09, 2023

BUY
N/A
75 Added 12.82%
660 $5,000
Q2 2023

Aug 08, 2023

BUY
$7.79 - $10.69 $4,557 - $6,253
585 New
585 $4,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.